Chromatographic Methods in Clinical Chemistry and Toxicology

Preface xi List of Contributors xiii 1. Quality Assurance, Quality Control and Method Validation in Chromatographic Applications 1 Michele L. Merves and Bruce A. Goldberger 1.1 Introduction 1 1.2 History 1 1.3 Definition of Quality Assurance and Quality Control 3 1.4 Professional Organizations 4 1.5 Internal Quality Assurance and Control 5 1.5.1 Standard operating procedure manual 5 1.5.2 Method development 5 1.5.3 Method validation 6 1.5.4 Accuracy 7 1.5.5 Precision 7 1.5.6 Recovery 7 1.5.7 Lower limits of detection (sensitivity) and quantitation 8 1.5.8 Range of linearity 8 1.5.9 Specificity 9 1.5.10 Stability 9 1.5.11 Carryover 9 1.5.12 Ruggedness 9 1.5.13 Selection of a reference standard 10 1.5.14 Selection of an internal standard and standard addition 10 1.5.15 Selection of derivatization agent 10 1.5.16 Selection of ions for selected-ion monitoring or full-scan analysis 11 1.5.17 Chromatographic performance 11 1.5.18 Statistical evaluation of quality control 11 1.6 External Quality Assurance 13 References 13 2. Liquid Chromatographic-Mass Spectrometric Measurement of Anabolic Steroids 15 Don H. Catlin, Yu-Chen Chang, Borislav Starcevic and Caroline K. Hatton 2.1 Introduction 15 2.2 LC-MS Analysis of Synthetic Steroids or Animal Samples 16 2.3 LC-MS Analysis of Natural Androgens in Human Samples 19 2.4 Conclusion 29 References 29 3. High-performance Liquid Chromatography in the Analysis of Active Ingredients in Herbal Nutritional Supplements 33 Amitava Dasgupta 3.1 Introduction 33 3.2 St John’s Wort 35 3.2.1 Drug interactions with St John’s wort 35 3.2.2 Measurement of active ingredients of St John’s wort using HPLC 36 3.2.3 Analysis of St John’s wort extract with other analytical techniques 38 3.2.4 Measurement of hypericin and hyperforin in human plasma using HPLC 38 3.3 Herbal Supplements with Digoxin-like Immunoreactivity 39 3.3.1 Use of HPLC for the determination of chan su, danshen and ginsengs 40 3.4 Herbal Remedies and Abnormal Liver Function Tests 41 3.4.1 Use of GC-MS and HPLC for the measurement of active components 43 3.5 Ginkgo Biloba 43 3.5.1 Analysis of components of ginkgo biloba by HPLC 44 3.6 Echinacea 45 3.6.1 Analysis of active components of echinacea by HPLC 45 3.7 Valerian 46 3.7.1 Analysis of components of valerian by HPLC 46 3.8 Feverfew 46 3.8.1 Analysis of parthenolide by HPLC 47 3.9 Garlic 47 3.9.1 Measurement of components of garlic by HPLC 48 3.10 Ephedra (Ma Huang) and Related Drugs 48 3.10.1 Analysis of active components of ephedra-containing products 49 3.11 Conclusions 50 References 50 4. Measurement of Plasma L-DOPA and L-Tyrosine by High-Performance Liquid Chromatography as a Tumor Marker in Melanoma 56 Thierry Le Bricon, Sabine Letellier, Konstantin Stoitchkov and Jean-Pierre Garnier 4.1 Introduction 56 4.2 Melanogenesis 57 4.2.1 Overview of the pathway 57 4.2.2 Potential tumor markers 58 4.3 L-DOPA Alone 59 4.3.1 Urine analysis 59 4.3.2 Blood (plasma or serum) analysis 59 4.4 L-DOPA/L-Tyrosine Ratio 60 4.4.1 Technical aspects 60 4.4.2 Clinical results 61 4.4.3 Future directions 63 4.5 Conclusion 64 References 65 5. Hypersensitive Measurement of Proteins by Capillary Isoelectric Focusing and Liquid Chromatography-Mass Spectrometry 67 Feng Zhou and Murray Johnston 5.1 Introduction 67 5.2 A Robust CIEF-RPLC Interface 69 5.3 First-Generation CIEF-RPLC-MS System for Proteins 71 5.4 Second-Generation CIEF-RPLC-MS System 76 5.5 Future Improvements 83 Acknowledgment 83 References 83 6. Chromatographic Measurement of Transferrin Glycoforms for Detecting Alcohol Abuse and Congenital Disorders of Glycosylation 87 Anders Helander 6.1 Introduction 87 6.2 Transferrin Microheterogeneity 88 6.3 Carbohydrate-deficient Transferrin (CDT) 89 6.4 Congenital Disorders of Glycosylation (CDG) 89 6.5 Analytical Methods for Transferrin Microheterogeneity 90 6.6 Chromatographic Methods for CDT 91 6.6.1 HPLC conditions and potential interferences 91 6.6.2 Chromatographic separation of transferrin glycoforms 92 6.6.3 Genetic transferrin variants and glycoform types 94 6.6.4 Sensitivity and reproducibility 94 6.7 Chromatographic Methods for CDG 94 6.7.1 HPLC testing for CDG 95 6.7.2 LC-MS testing for CDG 95 6.8 Summary and Conclusions 96 References 97 7. Chromatographic Measurements of Catecholamines and Metanephrines 101 Eric C. Y. Chan and Paul C. L. Ho 7.1 Background 101 7.1.1 Total or individual assays 104 7.2 Analytical Measurements of Catecholamines and Metanephrines 105 7.3 Early Methods 105 7.3.1 Catecholamines 105 7.3.2 Metanephrines 106 7.4 Current Chromatographic Methods 106 7.4.1 Chemistry of catecholamines 106 7.4.2 Specimen preparation 107 7.4.3 Fluorescence detection 109 7.4.4 Electrochemical detection 110 7.4.5 Chemiluminescence detection 112 7.4.6 Mass spectrometry 115 7.5 Practical Considerations for the Stability of Urinary Catecholamines and Metanephrines During Storage 117 7.6 Future Developments 118 Dedication 119 References 119 8. Chromatographic Measurement of Volatile Organic Compounds (VOCs) 127 Larry A. Broussard 8.1 Introduction 127 8.2 General Considerations 127 8.3 Intended Use 128 8.4 Volatility of Compounds 128 8.5 Sample Collection, Handling and Storage 129 8.6 Headspace Gas Chromatographic Methods 129 8.7 Columns and Detectors 130 8.8 Identification, Quantitation and Confirmation 130 8.9 Ethanol and Other Volatile Alcohols 131 8.10 Inhalants and Screening for Multiple VOCs 132 8.11 Interpretation 134 8.12 Conclusion 136 References 136 9. Chromatographic Techniques for Measuring Organophosphorus Pesticides 139 H. Wollersen and F. Musshoff 9.1 Introduction 139 9.2 Organophosphorus Pesticides (OPs) 141 9.2.1 Mechanism of action 141 9.2.2 Intoxication 141 9.2.3 Progression of intoxication and longer term risks 145 9.2.4 Therapy 146 9.2.5 Analytical procedures 146 9.3 Conclusion 163 References 164 10. Chromatographic Analysis of Nerve Agents 170 Jeri D. Ropero-Miller 10.1 Introduction 170 10.2 Neuromuscular Blockers 170 10.2.1 Background and uses 170 10.2.2 Classification, mechanism and duration of action 171 10.2.3 Effects and toxicity 173 10.2.4 Analysis 173 10.3 Paralytic Shellfish Poisoning: Saxitoxin 185 10.3.1 Background 185 10.3.2 Toxicity 187 10.3.3 Analysis 188 10.4 Summary 191 References 195 11. History and Pharmacology of c-Hydroxybutyric Acid 197 Laureen Marinetti 11.1 Introduction 197 11.2 History of Illicit Use of GHB 198 11.3 Clinical Use of GHB in Humans 200 11.4 History of Illicit Use of GBL and 1,4BD 200 11.5 Distribution and Pharmacokinetics of GHB, GBL and 1,4BD 202 11.6 GHB Interpretation Issues and Post-mortem Production 204 11.7 Analysis for GHB, GBL and 1,4BD 208 References 213 12. Liquid Chromatography with Inductively Coupled Plasma Mass Spectrometric Detection for Element Speciation: Clinical and Toxicological Applications 217 Katarzyna Wrobel, Kazimierz Wrobel and Joseph A. Caruso 12.1 Introduction 217 12.2 Liquid Chromatography with Inductively Coupled Plasma Mass Spectrometric Detection 218 12.3 Analytical Applications of Clinical and Toxicological Relevance 219 12.3.1 Arsenic 219 12.3.2 Iodine 234 12.3.3 Mercury 234 12.3.4 Platinum 240 12.3.5 Selenium 245 12.4 Conclusions and Future Trends 260 12.5 Abbreviations 260 References 262 13. Applications of Gas Chromatography-Mass Spectrometry to the Determination of Toxic Metals 274 Suresh K. Aggarwal, Robert L. Fitzgerald and David A. Herold 13.1 Introduction 274 13.2 Instrumentation 275 13.3 Experimental Procedure 276 13.3.1 Preparation of internal standard solutions 276 13.3.2 Digestion of biological sample 276 13.3.3 Preparation of metal chelate 277 13.4 GC-MS Studies 278 13.4.1 Memory effect evaluation 278 13.4.2 Precision and accuracy in measuring isotope ratios 281 13.4.3 Results of concentration determination of toxic metals in biological samples 283 13.5 Conclusions 284 References 284 Index 287